Reza Moghadasali1, Mahnaz Azarnia2, Mostafa Hajinasrollah3, Hassan Arghani4, Seyed Mahdi Nassiri5, Mohammad Molazem6, Ahmad Vosough7, Soroush Mohitmafi8, Mostafa Najarasl3, Zahra Ajdari3, Reza Salman Yazdi9, Mohsen Bagheri9, Hossein Ghanaati10, Behrooz Rafiei10, Yousof Gheisari11, Hossein Baharvand12, Nasser Aghdami13. 1. Department of Biology, Kharazmi University, Tehran, Iran; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Regenerative Medicine at the Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. 2. Department of Biology, Kharazmi University, Tehran, Iran. 3. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. 4. Urology and Nephrology Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 5. Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. 6. Department of Veterinary Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. 7. Department of Clinical Sciences, Faculty of Veterinary Medicine, Karaj Branch, Islamic Azad University, Karaj, Iran. 8. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Clinical Sciences, Faculty of Veterinary Medicine, Karaj Branch, Islamic Azad University, Karaj, Iran. 9. Department of Andrology at the Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. 10. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran. 11. Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran. 12. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Regenerative Medicine at the Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran. 13. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Regenerative Medicine at the Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Electronic address: Nasser.Aghdami@RoyanInstitute.org.
Abstract
BACKGROUND: Clinically, acute kidney injury (AKI) is a potentially devastating condition for which no specific therapy improves efficacy of the repair process. Bone marrow mesenchymal stromal cells (BM-MSCs) are proven to be beneficial for the renal repair process after AKI in different experimental rodent models, but their efficacy in large animals and humans remains unknown. This study aims to assess the effect of autologous rhesus Macaque mulatta monkey BM-MSC transplantation in cisplatin-induced AKI. METHODS: We chose a model of AKI induced by intravenous administration of 5 mg/kg cisplatin. BM-MSCs were transplanted through intra-arterial injection. The animals were followed for survival, biochemistry analysis and pathology. RESULTS: Transplantation of 5 × 10(6) cells/kg ameliorated renal function during the first week, as shown by significantly lower serum creatinine and urea values and higher urine creatinine and urea clearance without hyponatremia, hyperkalemia, proteinuria and polyuria up to 84 d compared with the vehicle and control groups. The superparamagnetic iron oxide nanoparticle-labeled cells were found in both the glomeruli and tubules. BM-MSCs markedly accelerated Foxp3+ T-regulatory cells in response to cisplatin-induced damage, as revealed by higher numbers of Foxp3+ cells within the tubuli of these monkeys compared with cisplatin-treated monkeys in the control and vehicle groups. CONCLUSIONS: These data demonstrate that BM-MSCs in this unique large-animal model of cisplatin-induced AKI exhibited recovery and protective properties.
BACKGROUND: Clinically, acute kidney injury (AKI) is a potentially devastating condition for which no specific therapy improves efficacy of the repair process. Bone marrow mesenchymal stromal cells (BM-MSCs) are proven to be beneficial for the renal repair process after AKI in different experimental rodent models, but their efficacy in large animals and humans remains unknown. This study aims to assess the effect of autologous rhesus Macaque mulatta monkey BM-MSC transplantation in cisplatin-induced AKI. METHODS: We chose a model of AKI induced by intravenous administration of 5 mg/kg cisplatin. BM-MSCs were transplanted through intra-arterial injection. The animals were followed for survival, biochemistry analysis and pathology. RESULTS: Transplantation of 5 × 10(6) cells/kg ameliorated renal function during the first week, as shown by significantly lower serum creatinine and urea values and higher urine creatinine and urea clearance without hyponatremia, hyperkalemia, proteinuria and polyuria up to 84 d compared with the vehicle and control groups. The superparamagnetic iron oxide nanoparticle-labeled cells were found in both the glomeruli and tubules. BM-MSCs markedly accelerated Foxp3+ T-regulatory cells in response to cisplatin-induced damage, as revealed by higher numbers of Foxp3+ cells within the tubuli of these monkeys compared with cisplatin-treated monkeys in the control and vehicle groups. CONCLUSIONS: These data demonstrate that BM-MSCs in this unique large-animal model of cisplatin-induced AKI exhibited recovery and protective properties.
Authors: Scott R Burks; Ben A Nguyen; Pamela A Tebebi; Saejeong J Kim; Michele N Bresler; Ali Ziadloo; Jonathan M Street; Peter S T Yuen; Robert A Star; Joseph A Frank Journal: Stem Cells Date: 2015-04 Impact factor: 6.277
Authors: Federico Franchi; Karen M Peterson; Rende Xu; Brent Miller; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Martin Rodriguez-Porcel Journal: Cell Transplant Date: 2014-10-06 Impact factor: 4.064
Authors: Holger Hackstein; Anne Lippitsch; Philipp Krug; Inna Schevtschenko; Sabine Kranz; Matthias Hecker; Kristina Dietert; Achim D Gruber; Gregor Bein; Cornelia Brendel; Nelli Baal Journal: Respir Res Date: 2015-10-06
Authors: Maria José Santiago; Sarah Nicole Fernández; Alberto Lázaro; Rafael González; Javier Urbano; Jorge López; Maria José Solana; Blanca Toledo; Jimena Del Castillo; Alberto Tejedor; Jesús López-Herce Journal: PLoS One Date: 2016-02-12 Impact factor: 3.240
Authors: Franziska Münz; Ramon Lopez Perez; Thuy Trinh; Sonevisay Sisombath; Klaus-Josef Weber; Patrick Wuchter; Jürgen Debus; Rainer Saffrich; Peter E Huber; Nils H Nicolay Journal: Sci Rep Date: 2018-01-10 Impact factor: 4.379
Authors: Nils H Nicolay; Ramon Lopez Perez; Alexander Rühle; Thuy Trinh; Sonevisay Sisombath; Klaus-Josef Weber; Anthony D Ho; Jürgen Debus; Rainer Saffrich; Peter E Huber Journal: Sci Rep Date: 2016-01-25 Impact factor: 4.379